Joe Sardano, Co-Founder, Chairman and CEO of Sensus Healthcare (NASDAQ: SRTS), spoke to our hosts about the company’s superficial radiotherapy technology, new Medicare reimbursement developments, and the growing demand for non-invasive treatment options for skin cancer and other superficial conditions.
February 7, 2023
